Zanamivir

Zanamivir is the first of two registered neuraminidase inhibitors for the treatment and prophylaxis of influenza. Zanamivir could inhibit SARS-CoV-2 3CLpro main protease.

Price Not Available 10mg Zanamivir Supplier Page
Trivial name GG167
Catalog Number CSN12229
Alternative Name(s) GG167
Research Area Infection
Molecular Formula C12H20N4O7
CAS# 139110-80-8
Purity ≥99%
SMILES O=C(C1=C[C@H](NC(N)=N)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O1)O
Size 10mg
Supplier Page https://www.csnpharm.com/products/zanamivir.html